Morten Sogaard

Morten Sogaard

Company: Astellas Innovation Management

Job title: President, Research & TechOps

Seminars:

Panel Discussion: Breaking Boundaries: Navigating the Shift from Rare to Common Diseases in Gene Therapy 1:30 pm

• Exploring the unique challenges and benefits of expanding gene therapy into more prevalent conditions, including patient access, cost, and treatment scalability • Evaluating the feasibility of widespread gene therapy applications in common diseases by 2025, along with realistic goals and potential hurdles • Essential factors for successful translation, including regulatory preparedness, CMC adaptation, and…Read more

day: Focus Day

Opening Remarks & Group Introductions 9:00 am

Read more

day: Focus Day

Effective Strategies for Transitioning from Rare to Common Diseases to Expand Gene Therapy Horizons 9:30 am

• Analysis of the challenges and opportunities in scaling gene therapy technologies from rare to common diseases, including adjustments in clinical trial design and patient populations • Examination of strategies to reduce production costs and enhance cost-effectiveness while maintaining high-quality standards for larger patient populations • Insights into the regulatory hurdles and market strategies required…Read more

day: Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.